Sanaz N Ghafouri

3PUBLICATIONS
25CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 23, 2022
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma.

Sarah M Larson, Christopher M Walthers, Brenda Ji

|Apr 11, 2022
Chemotherapy regimen choice and patient outcomes in early-stage triple-negative breast cancer: a retrospective analysis.

Sanaz N Ghafouri, Rebecca W Nayeri, Nicholas P McAndrew

|Nov 10, 2020
Axicabtagene Ciloleucel CAR T-cell therapy for relapsed/refractory secondary CNS non-Hodgkin lymphoma: comparable outcomes and toxicities, but shorter remissions may warrant alternative consolidative strategies?

Sanaz Ghafouri, John Timmerman, Sarah Larson

Pageof 1

Frequent Collaborators

1 joint publications

Sarah M Larson

1 joint publications

Christopher M Walthers

1 joint publications

Brenda Ji

1 joint publications

Jacob Naparstek